Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
reproductive health
MedTech
Organon pays $27.5M upfront for Sebela's hormone-free copper IUD
Organon is grabbing global licensing rights to Sebela's hormone-free copper intrauterine device in a deal potentially worth more than $532 million.
Natalie Missakian
Feb 24, 2026 4:25am
PacBio launches carrier screening panel in reproductive health
Sep 22, 2025 11:00am
Take 2: CooperSurgical pays $300M for Cook Medical assets
Nov 3, 2023 10:28am
Ferring's research site closure signals shift from internal R&D
Apr 11, 2023 11:22am
Sema4 lays off 448 employees, exits reproductive health testing
Nov 18, 2022 10:42am
CooperSurgical to buy Cook's IVF, OB-GYN portfolio for $875M
Feb 8, 2022 10:45am
